Insider · CIK 0001964479
David Elias Fleischman
Files at ANGI (Angi Inc.). First filing -, latest -.
In brief
David Elias Fleischman files SEC Form 4 as officer at ANGI (Angi Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David Elias Fleischman has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 6, 2025 | ANGI Angi Inc. | MOption exercise Class A Common Stock, par value $0.001 | +441,696 | $0.00 | $0 | 768,685 | Feb 7, 2025 |
| Feb 6, 2025 | ANGI Angi Inc. | FTax withholding Class A Common Stock, par value $0.001 | -113,870 | $1.78 | $203k | 654,815 | Feb 7, 2025 |
| Feb 6, 2025 | ANGI Angi Inc. | MOption exercise Restricted Stock Unitsderivative | -441,696 | $0.00 | $0 | 883,392 | Feb 7, 2025 |
Questions about David Elias Fleischman
Answered from the filings on this page, as of the latest one.
Is David Elias Fleischman buying or selling?
David Elias Fleischman has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David Elias Fleischman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Elias Fleischman has 0.
Where does David Elias Fleischman file Form 4?
David Elias Fleischman has filed Form 4 at ANGI (Angi Inc.) as Chief Product Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.